Paper Review Records
All Paper Review Records
19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
153
days
A Noncanonical MET Exon 14 Splice‐Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib
AuthorsHyung‐Joo Oh; Yoo‐Duk Choi; Yoon‐La Choi; Ha‐Young Park; Joon‐Young Yoon; Jang‐Hyeon Kim; Jung‐Hwan Lim; Cheol‐Kyu Park; In‐Jae Oh; Young‐Chul Kim
Affiliations1. Division of Pulmonology, Department of Internal Medicine Chonnam National University Medical School Gwangju South Korea; 2. Lung Cancer Center Chonnam National University Hwasun Hospital Gwangju South Korea; 3. Department of Pathology Chonnam National University Medical School Gwangju South Korea; 4. Department of Pathology & Translational Genomics Samsung Medical Center, Sungkyungwan University School of Medicine Seoul South Korea
82
days
Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2 ‐Positive Metastatic Breast Cancer: A Single‐Center Pooled Analysis
AuthorsJialin Lin; Qiao Li; Pin Zhang; Ying Fan; Ruigang Cai; Yang Luo; Bo Lan; Shanshan Chen; Jiani Wang; Hongnan Mo; Fei Ma; Jiayu Wang; Binghe Xu
Affiliations1. Department of Medical Oncology National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 2. Beijing Key Laboratory of Innovative Drug R&D and Translational Research for Breast Cancer Beijing China
165
days
Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines
AuthorsYani Wu; Fang Cao; Jiayin Dai; Zhenli Yang; Yanli Zhu; Dongmei Lin; Xiaocui Bian; Yuqin Liu
Affiliations1. Department of Pathology, Cell Resource Center, Institute of Basic Medical Sciences and School of Basic Medicine Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 2. Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital and Institute Beijing China
194
days
Advanced Thymoma and Advanced Thymic Carcinoma Treatment Practices in 2018–2022: A Nationwide Analysis in Japan
AuthorsJunichi Ishigaki; Ryoko Rikitake; Hidenori Kage; Takahiro Higashi
Affiliations1. Department of Public Health and Health Policy, Graduate School of Medicine The University of Tokyo Tokyo Japan; 2. Department of Respiratory Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan; 3. Rare Cancer Center National Cancer Center Hospital Tokyo Japan; 4. Division of Health Services Research Institute for Cancer Control, National Cancer Center Tokyo Japan
137
days
ctDNA Detection of Polyclonal KRAS Resistance in Adagrasib‐Treated NSCLC
AuthorsMarion Caumeil; Julie A. Vendrell; Simon Cabello‐Aguilar; Sarah Cavaillon; Quentin Dominique Thomas; Jérôme Solassol
Affiliations1. Laboratoire de Biologie des Tumeurs Solides, CHU Montpellier Université de Montpellier Montpellier France; 2. MOBIDIC Montpellier France; 3. Institut du Cancer de Montpellier (ICM) Montpellier France; 4. Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM) Montpellier France
75
days
Sequential EGFR T790M , MET c. 3010C >G‐Associated Exon 14 Alteration, and RET ‐ CCDC6 Fusion in EGFR ‐Mutant NSCLC : A Case Report
AuthorsYan Zhu; Chan Wang; Nan‐Lin Hu; Dan‐He Wang; Shi‐Kai Wu
Affiliations1. Department of Oncology Peking University First Hospital Beijing China
46
days
Cardiac Vigilance Beyond Hypertension With Lenvatinib in Thymic Carcinoma
AuthorsAshish Gupta; Amulya Gade; Ashish Subedi
Affiliations1. Internal Medicine Cape Fear Valley Medical Center Fayetteville North Carolina USA
127
days
EGFR Mutations and Recurrence Outcomes in Resected Non‐Small Cell Lung Cancer: An Updated 2015–2025 Systematic Review and Meta‐Analysis
AuthorsSoo Han Kim; Hayoung Seong; Hyojin Jang; Saerom Kim; Wanho Yoo; Jeongha Mok; Kwangha Lee; Ki Uk Kim; Min Ki Lee; Mi‐Hyun Kim; Jung Seop Eom
Affiliations1. Department of Internal Medicine Pusan National University School of Medicine Busan Republic of Korea; 2. Department of Internal Medicine Pusan National University Hospital Busan Republic of Korea; 3. Biomedical Research Institute, Pusan National University Hospital Busan Republic of Korea
76
days
The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio ( NLR ) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA – IIIB Non‐Small Cell Lung Cancer in Real‐World Practice
AuthorsDi Meng; Jiacong Liu; Gaoqi Ye; Linhai Zhu; Xuhua Huang; Xiayi Lv; Jian Hu
Affiliations1. Department of Thoracic Surgery, the First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China; 2. Key Laboratory of Clinical Evaluation Technology for Medical Device of Zhejiang Province Hangzhou China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days